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Leukemia was first described during the middle of the nineteenth
century.4'
" Subsequent hematologic and bacteriologic study by
numerous investigators demonstrated that human leukemia in none
of its forms could be related to any definitive bacterial, animal para-
sitic, or filterable agent. Much of the descriptive pathological work
has centered about the classification of this intriguing disease; what
is its relation to the neoplasms (lymphosarcoma, leukosarcoma, mul-
tiple myeloma), the atypical granulomata (Hodgkin's disease, myco-
sis fungoides), and the hyperplastic hemopoietic responses to infec-
tious agents? In the century following the original descriptions
progress has been made in the classification of the morphological and
clinical types of the disease, but little more is known concerning its
etiology than when Bennett and Virchow first recognlized leukemia
as a distinct entity.
The first step in leukemia investigations beyond the descriptive
phase was made by Ellerman"5 in 1908, when he demonstrated that
fowl leukemia can be transmitted to normal chickens by inoculation
of either leukemic cells or cell-free filtrates derived from the blood
or tissues of leukemic animals. Subsequent investigations confirmed
this pioneer work. The neoplastic nature of chicken leukemia is now
rather generally accepted; Ellerman was, unknown to himself,
among the first to transfer a neoplasm to a new host by inoculation of
cell-free extracts of neoplastic tissues.
In 1926-27 Snijders89 and Tio Tjwan Gie,95 in Holland,
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descrilbed leukemia and lymphosarcoma in the guinea-pig and dem-
onstrated that these diseases can be transferred to susceptible animals
only by inoculation of intact leukemic or sarcomatous lymphocytes.
Unlike the situation in the chicken, inoculations of cell-free filtrates
did not transmit the disease. It was concluded that the cells intro-
duced gave rise to all the cells of the leukemic process in the new
host; the latter's tissues produced none of the malignant or leukemic
lymphocytes.
Richter and MacDowell8" reported the experimental transmis-
sion of leukemia in the C58 strain of mice in 1929. Since this date
the bulk of the work in experimental leukemia has been done on the
mouse. Three inbred strains of mice (C58, Ak, and F) exhibiting a
high incidence ofspontaneous leukemia, various sublines of strain dba
in which leukemia can be induced readily with carcinogens, and
several low-leukemia strains in which leukemia develops after
administration of x-rays or estrogens, are being investigated in this
country. These mice represent excellent material for controlled
studies on leukemia and lymphosarcoma in this species.
The nature of mouse leukemnia
Leukemia in the mouse is similar to human leukemia morpho-
logically and clinically. Bone-marrow and blood smears, and tissue
sections of mouse lymphatic leukemia are indistinguishalble from
similar preparations of the human disease.25' 46, 86 The spontaneous
diseases ofboth species are invariably fatal and react in the same way
to x-irradiation. After treatment dinical improvement might be
evident, but there is ultimately an acute exacerbation of the disease."7
Since the members ofastrain of mice are so closely related, tissue
grafts are to be considered practically autologous. Consequently,
leukemic lymphocytes or granulocytes can be inoculated into mice
of the same strain and remain viable. They not only survive, but
proliferate and consistently give rise to leukemia in the new host.
When inoculated subcutaneously leukemic cells form a tumorous
nodule; from this they metastasize to various organs of the host.
The tissue of the inoculated animal does not proliferate any of the
leukemic cellS.29' 46, 81
In the light of these experiments in a species where leukemia is
decidedly similar to, if not identical with, human leukemia, the
classical concept of the diffuse origin of leukemic cells from the gen-
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eral mesenchymal tissue of the human has been subjected to criti-
cism.25 The theory of diffuse "local" rather than "infiltrative"
origin of leukemic lesions has been used, for obscure reasons, as an
argument in favor of "hyperplasia" as opposed to "neoplasia." In
the first place, multicentric origin would be compatible with the neo-
plastic concept of leukemia, and second, it is doubtful that human
leukemic lesions are all local in origin from the mesenchyme or
reticulum of the organ involved. In terminal cases (and this is the
type of material from which most deductions have been made) it
is not possible objectively to make the distinction between "in situ"
origin of cells and "infiltration." In the mouse "systemic leukemia,"
so-called, can result from a single focus of transplanted cells without
origin ofleukemic cells fromthe host itself; Furth and Kahn28 intro-
duced a single cell intosusceptible mice with, in several instances, the
ultimate development of uniformly widespread leukemic lesions.
Potter, Victor, and Ward83 have observed what they interpret
as preleukemic reticulo-endothelial proliferations of the interfollicu-
lar tissue of mouse lymph nodes and the loose connective tissue sur-
rounding the central veins of the liver. These lesions did not prove
to be widespread within any one mouse. In mice of the C58 strain
the first external evidence of the imminent development of spontane-
ous leukemia is, in many cases, a single enlarged lymph node. Such
lymph nodes were excised and inoculated as cellular suspensions
intraperitoneally into normal young (preleukemic age group) mice
of the same strain.9" These animals developed transplanted leuke-
mia shortly after inoculation, whereas the donor did not become
leukemic until a significantly later date, that is, until a new focus of
reticulo-endothelial proliferation appeared.
Systemic leukemia can, according to the above investigators, arise
from a single neoplastic focus in the mouse. A single localized area
oflymphoid neoplasia could thus produce as an end-result either leu-
kemia or lymphosarcoma, depending on the invasive character of the
cells proliferated from the reticulo-endothelial mother tissue. Some
malignant lymphocytes, for example, are able to enter the blood
stream readily, colonize throughout the body, and give rise to "sys-
temicleukemia"; other more infiltrative lymphocytes enter the blood
stream to a lesser extent, and when they do so they produce infiltrat-
ing lymphosarcomatous growths at the points of escape from the
capillaries. Some sarcomatous lymphocytes fail to survive when
injected into the blood stream of a host susceptiible to extra-vascular
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inoculation of the same cells.43 Many lines* of leukemic and sarco-
matous lymphocytes exhibiting varying degress of infiltrative and
metastatic capability have been studied. Those which produce large
tumors when inoculated subcutaneously invade the blood stream less
readily than do those which produce very small flat tumors.25 29, 43
The type of growth produced by leukemic cells depends on the
host in which the cells proliferate as well as on the intrinsic cellular
physiology. Previous irradiation ofan animal29 orpartial immuniza-
tion62 may determine the sarcomatous or leukemic nature of inocu-
lated cells.
Mouse leukemia with multicentric foci of origin has appeared
following the administration of carcinogens."9 This finding is in
keeping with the neoplastic nature of leukemia in this species;
induced lung tumors are usually multiple, and there were literally
hundreds of foc of neoplastic activity in the mammary glands of
strain diba female breeders which had been skin-painted with methy-
cholanthrene dissolved in benzene.44 Instances of multiple origin of
cancer are to be found in human pathology. There have been no
reports concerning the mother tissue of induced leukemia. Whether
the leukemic transformation begins in the reticulum, as has been
suggested for spontaneous leukemia in the C58 strain of mice83 and
in man,90 or in the definitive lymphoid cells is not known.
There are no specific cytomorphologic criteria for lymphoid or
myeloid malignancy.46, 80, 84 Leukemic cells of the tissues are often
"immature" in appearance. In dry imprint preparations the cyto-
plasm of these cells is basiphilic; granular nuclear basichromatin is
more readily and sharply stained, and nucleoli are more prominent
than in normal immature cells. Leukemic cells may, however, have
nuclei lacking the fine sieve-like chromatin pattern and nucleoli
characteristic of immaturity; heavy blocks of nuclear chromatin and
intensely basiphilic cytoplasm may characterize the lymphocytes of
certain leukemias.29 31 46
Individual immature cells which are indistinguishable from cer-
tain leukemic cells may be selected from dry imprint preparations of
normal lymph nodes and bone marrow; deeply basiphilic circulating
lymphocytes of the normal mouse are similar morphologically to
* Following MacDowell and Richter, the term "line" is used to indicate cell
lineage in successive transfers. "Strain" refers to the ancestral succession of animals
of the same genetic constitution controlled by pedigreed inbreeding.
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the basiphilic lymphocytes which are found in increased number in
the peripheral blood of some leukemias. The general pattern of
hemopoiesis rather than individual cellular morphology is of prime
importance in diagnosis. In certain instances benign myeloid meta-
plasia in the mouse may be indistinguishable morphologically from
myeloid leukemia,3 and transplantation studies must be resorted to
as a physiological test for malignancy. In the human the same
problem has arisen in distinguishing between benign and leukemic
extramedullary hemopoiesis.
Experiments on the mouse have confirmed the impressions of
most pathologists concerningthe neoplastic nature ofleukemia. The
view has been expressed that chronic leukemias are hyperplastic,
whereas acute leukemias might be neoplastic.9" A chronic leukemia
of the mouse can, however, be transformed into an acute leukemia
by passage through numerous hosts.25 29, 4 Whether acute or
chronic, mouse leukemias are transplantable and exhibit the character-
istics of neoplasms. A graded series can be found in both the mouse
and human between lymphosarcoma and leukemia. The chloromas
represent myeloid leukemia with tumor-forming potentialities. In
man Hodgkin's disease can be related to these conditions when the
clinical and morphological similarities between this disease and
lymphosarcoma are considered.
Lymphatic leukemia, myelogenous leukemia, and lymphosar-
coma all appear spontaneously in the F strain of mice" After many
inibred generations, when further genetic selection is not likely, all
three conditions may appear among the brothers and sisters of the
same litter. This would suggest that lymphosarcoma and these
two types of leukemia are different morphological manifestations
of the same disease. Although the mice are homogeneous geneti-
cally, they do not all develop the same type of leukemia simultane-
ously; in fact, some remain free from the disease although their
offspring develop leukemia. Unknown non-genetic factors may be
responsible for some of these variations, and for the failure of from
40 to 45 per cent of strain F mice to develop leukemia or lymphosar-
coma. As in the case of human leukemia, mouse leukemia occurs
sporadically in populations which possess no particular known genetic
susceptibility to the unknown factor or factors responsible for the
disease.50 As in tihe mouse, human leukemia has been known to
appear on a genetic basis.11
Chicken leukemia bears the same relation to mammalian leuke-
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mia that the other "filterable" tumors of the chicken bear to mam-
maliarL neoplasms. The viral agen't of chicken leukemia can be
sedimented by ultracentrifugation, although isolation of the agent
is not so exact as in the case of the Rous sarcoma.45 Whether the
"macromolecular material" sedimented by high-speed centrifugation
is the agent itself, or representative of the material onto which the
agent might be adsoPbed, has not been settled. Similar sediments
are obtainable by the same methods from both normal tissues and
tumors Which are not associated with a filterable agent. The presence
in mammalian leukemia tissue of an agent which can be separated
from the cells has been reported,", 78 but this has not been cor-
roborated.
The induction of mouse leukemia
Carcinogens: Morton and Mider71 72 demonstrated conclusively
that administration of carcinogens resulted in an increased incidence
and an accelerated appearance of leukemia in strain dba mice; inde-
pendent investigations on this and other strains have yielded similar
results.7 17, 26, 48, 50, 52, 54, 57 Thirty per cent of dba mice of sub-line
212 developed the disease spontaneously, whereas 90 per cent were
leukemic approximately 100 days after bi-weekly skin paintings
with a 0.5 per cent solution of methylcholanthrene in benzene had
been instituted. The latent period of carcinogenic induction was
prolonged if 3,4-benzpyrene rather than methylcholanthrene was
used. Similar treatment with carcinogens hastened the appearance
of leukemia in two high-leukemia strains, Ak and F,21 48, 50 but
decreased the total incidence of the disease, since many mice died of
neoplasms other than leukemia. The carcinogenic hydrocarbon, 1,2,-
5,6-dibenzanthracene, in general a less potent carcinogen than benz-
pyrene or methylcholanthrene, proved not to be leukemogenic for
the F strain. Several strains of mice (NH, C57, CHI, A,) with a low
incidence of spontaneous leukemia failed to respond to the leukemia-
inducing activity of carcinogens.41 48 50 On the other hand, some
low-leukemia strains (Swiss, Rf, C3H, Buffalo) developed a high
leukemia incidence following treatment with carcinogenic chemi-
cals.52, 7' Genetic susceptibility to the leukemogenic activity of car-
cinogens would seem not to be synonymous with susceptibility to the
development of spontaneous leukemia, although there seems to be
some degree ofpositive correlation. Carcinogens may induce in mice
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susceptible to spontaneous leukemia a malignant lymphoid or mye-
loid deviation unrelated genetically to the spontaneous leukemic
transformation.21' 87
The route of administration and the solvent of the carcinogen
can determine its effectiveness as a leukemogenic agent. For the F
strain methylchiolanthrene was leukemogenic when dissolved in ben-
zene and applied percutaneously; when administered in the same
fashion dissolved in sesame oil its leukemia-inducing potency was
lost.41 The presence of cotton-seed oil on the fur of the mice fed a
high-fat diet probably was the factor resulting in prolongation of the
period of carcinogenic induction when methylcholanthrene dissolved
in benzene was applied percutaneously.5 Intravenous injection of
methylcholanthrene suspended in horse serum induced mammary
cancer but not leukemia in the F strain.48 The leukemogenic activity
of methylcholanthrene for the dba strain was enhanced when the
solvent was ibenzol rather than acetone, the route of administration
being percutaneous.71 In the F strain, mice which did not develop
skin tumors readily following the percutaneous application of car-
cinogens were more susceptible to the induction of leukemia than
were those which developed skin papillomas and carcinomas rela-
tively early.48 The incidence of carcinogen-induced leukemia was
reduced in dba females of sub-line 12 which were allowed to breed
and which developed mammary cancer during the course of treat-
ment with carcinogens.44
Estrogens: Gardner and his associates31, 32 demonstrated that the
incidence of leukemia in certain low-leukemia strains was increased
appreciably when estrogenic hormone was administered in relatively
large doses over a long period of time. Mice of certain strains,
and especiallythe females in some stocks, were more susceptible than
were others.31 Generalized osteosclerosis was associated with the
development of leukemia. The development of both osteosclerosis
and leukemia could be inhibited if androgenic hormone was given in
appropriate quantity simultaneously with the estrogen.
A higher incidence of leukemia has been noted in the females of
certain strains.'2 Ovariectomy resulted in a decreased leukemia
incidence in the high-leukemia Ak strain; following orchidectomy
the incidence was slightly elevated.70 Such an influence of endogen-
ous estrogen was not suggested in the case of induced leukemia in
strain dba71 or spontaneous leukemia in strain F.40 Ovarieotomy did
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not inhibit the spontaneous development of leukemia in strain F
mice; the adrenals of the castrate animals were not adenomatous and
did not serve as a source of estrogenic hormone.
X-rays: The incidence of leukemia has been reported to be
higher in x-ray workers than in the general population.34' Krebs
and his associates5 observed an increased incidence of leukemia
among pen-bred mice exposed to x-rays. Because of the lack of
adequate controls of similar genetic background to the test animals,
this work cannot be considered reliable. The first adequately con-
trolled experiments indicating the leukemogenic action of x-rays were
those of Furth,"9 in which the incidence of leukemia was increased
threefold within an inbred strain by exposure to x-rays. The inci-
dence of myelogenous leukemia, especially, was elevated. Furth and
Boon22 have demonstrated also that x-rays can act synergistically with
the carcinogenic hydrocarbons if the test mice are susceptible to the
induction of leukemia with each of the agents administered singly.
This synergism was not demonstrable for strain dba; the suscepti-
bility of these mice to the leukemogenic action of methylcholan-
threne was not altered by previous exposure to x-rays.38
The genetic constitution of the mouse conditions its reaction to
x-rays. In some strains leukemia can be induced by this physical
agent, whereas other strains are resistant to its leukemogenic action.
Susceptibility to the induction of leukemia with x-rays cannot be
correlated with susceptibility to spontaneous leukemia or to the
leukemogenic action of carcinogens.37 Strain dba proved susceptible
to the carcinogenic induction of leukemia, but leukemia was not pre-
cipitated 'by exposure to x-rays. On the other hand, strain A mice
are resistant to both spontaneous and carcinogenic induction of leu-
kemia, but they are susceptible to the induction of leukemia by
x-rays.
Benzol: It has been stated often in the literature that exposure
to benzol can result in the development of leukemia in the human
subject. Lignac reported the induction of leukemia in market mice
by the periodic injection subcutaneously of benzol dissolved in olive
oil.59 Although benzol proved to favor the leukemogenic activity
of methylcholanthrene when used as a solvent for this carcinogen
(as compared with acetone as a vehicle), benzol alone was probably
not leukemogenic for the dba strain.7' Percutaneous application of
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48
benzol did not accelerate the onset of leukemia in the F strain.
To establish definitely the diagnosis of leukemia in mice the disease
should be transferred by inoculation of viable cells into susceptible
mice. Unless mice of known genetic constitution are used in experi-
ments on the induction of leukemia the results are open to question,
since leukemia occurs spontaneously in market mice. It would seem
that the leukemogenic action of benzol has not been demonstrated
conclusively experimentally; it is possible, however, that it induces
leukemia in animals of the appropriate genetic constitution.
Miscellaneous agents have been said to be leukemogenic.5 11
Proper evaluation of such studies must await further experimenta-
tion on mice and rats of inbred strains where the age incidence of
leukemia among controls is known. Because of the association of
infection with leukemia (probably as a result of decreased resistance
secondary to leukemia) it is desirajble that bacteria and their toxins
be studied experimentallyunder controlledconditions as precipitating
agents for leukemia. Purpura, elevated temperature, acute onset
with prostration, and increased metabolic rate have prejudiced many
clinicians in favor of the idea that leukemia is an atypical response to
an infectious agent. There are no supporting epidemiological studies,
nor have Koch's postulates been satisfied for any of the bacterial
agents isolated from cases of leukemia.
It has been postulated that there is a substance in the urine of
patients with myelogenous leukemia which produces hyperplasia of
the bone marrow and extramedullary hemopoiesis when injected
into guinea-pigs; extracts of urine from patients with lymphatic leu-
kemia or multiple myeloma are said to have produced hyperplasia
of the lymphoid elements.100
In general, it might beconcluded that various agents are effective
in inducing leukemia or in accelerating its onset depending on the
genetic constitution of the mice used for experimentation. Because
a strain of mice is susceptible to the action of one such agent does not
imply necessarily that the animals are susceptible to another agent
which has been shown to be leukemogenic for still another strain.
The problem of leukemogenesis in mice is very complex. First,
multiple agents can induce leukemia. Second, mice of only certain
genetic constitution are susceptible to only certain agents. Third,
genetic susceptiibility to one agent, or to the spontaneous disease, can-
not necessarily be cqrrelated with susceptibility to other leukemo-
genic agents. Fourth, synergists condition the response to carcino-
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gens; synergists vary in their effectiveness with the strain of animal
involved.
The following table illustrates the principle of multiple leuke-
mogenic factors in mice:-
Precipitating agent
Strain of Unknown factors of spoz-
mice Estrogens X-rays Carcinogens taneous leutkemia
C3H + e
A + ++ -
F _++ 1-l-
dba(l2) ?4--
dba(212) ?- IHI+++
Rf +++ ++
Ak ? t 1 H
C58 -
Genetics of mouse leukemia
MacDowell and Richter found that the incidence of leukemia in
hybrids could be roughly correlated with the total heredity from the
high-leukemia C58 strain when C58 hice were crossed with low-leu-
kemia StoLi animals.6 A "maternal influence" was suggested, for
if the female parent was of the C58 strain the incidence of leukemia
was 20 per cent greater than in the reciprocal cross. Cole and
Furth 12 working with the Ak and Rf stocks, concluded that suscepti-
bilityto leukemia is probably inherited as a multiple-factor character,
and is influenced byundetermined environmental factors. In various
crosses the common logarithm of the per cent leukemia was a simple
function of the per cent heredity from the high-leukemia stock.
Female mice had a higher incidence of leukemia than had males. It
was concluded that the genetic basis for spontaneous leukemia may
vary for different stocks of mice, since Mercier73 had observed that
susceptibility to spontaneous lymphosarcoma was inherited as a sim-
ple Mendelian recessive character, and the results of MacDowell and
Richter were somewhat at variance with those of Cole and Furth.
In later experiments with the Ak stock, Furth, Boon, and Kaliss2"
found that when animals of this stock were crossed with the C3H
rather than With the Rf stock the incidence of leukemia in the F1
hybrids was higher; if the female parent was of the C3H strain the
incidence of leukemia was 50 per cent, as compared with an incidence
of 34 per cent in the reciprocal cross.
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When the high-leukemia F strain was crossed with three low-
leukemia stocks (CBA, A, and C57), the incidence of leukemia in F,
hybrids and in 'backcrosses to the high-leukemia stock was approxi-
mately the same as in the pure F stock.40 In the backcross popula-
tion to the low-leukemia stock the incidence of leukemia was proba-
bly reduced, although a high percentage of the animals of this group
died of other causes (polycystic kidney disease and mammary can-
cer), thus complicating the picture.
The most significant finding in hybrid animals was the delayed
appearance of leukemia (as compared with animals of the pure F
stock). The data of other workers indicate that the same was true
in their studies.'12 65
The delay in the appearance of leukemia and lymphosarcoma
could be correlated with (1) the degree of inheritance from the F
strain and/or (2) the increased life expectancy in hybrids. The
latter, however, seemed to depend to some extent on the strain F
genic contribution. For example, life expectancy was greater in F,
hybrids than in backcrosses to the F strain. Leukemia appeared in
approximately the same percentage in both groups, but the onset was
later in the F, hybrids. Thus, with a greater life expectancy leu-
kemia appeared later in life. Life expectancy was no greater, how-
ever, in backcrosses to the low-leukemia stock than in F, hybrids.
Still, the onset of leukemia seemed to be delayed as compared with
the F, hybrids. This would suggest a direct correlation between
the age of appearance of leukemia and the quantitative genic contri-
bution from the F strain; the greater the number of strain F genes
in a hybrid animal, the earlier leukemia appeared. For the hetero-
geneous F2 population the appearance of leukemia was scattered
through the various age groups. MacDowell observed a maternal
influence for longevity; F, hybrid mice receiving this influence from
the low-leukemia strain developed leukemia later in life than did F,
hybrids of the reciprocal cross.6"
It is possible that hybrid animals possess a greater degree of
resistance towards the unknown causative "agent" of mouse leuke-
mia, and consequently the disease appears later in life and in a more
chronic form. With an increased life expectancy metabolic differ-
ences might be expected to delay the onset and alter the character
of neoplastic change.
In determining the incidence of leukemia in hybrid animals it is
of utmost importance that intercurrent infection and the appearance
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of other neoplasms be reduced to a minimum, and that environmen-
tal conditions be optimal sothat sufficient time is given forthe genetic
capability to become manifest. Unless these factors are equally con-
trolled in all experiments, the data of independent investigators are
not comparable.
Although mice of strain dba develop leukemia when skin-painted
with carcinogenic hydrocarbons, F, hybrids resulting from a cross
between dba males and C3H females (with or without the mammary
cancer milk-influence) did not become leukemic when similarly
treated.4" Either susceptibility to carcinogenic induction of leu-
kemia in this strain is inherited as a recessive character, or in hybrids
the latent period of induction is prolonged to such an extent that the
animals die first of skin tumors, or perhaps a milk-influence from
dba female mice conditions the response to methylcholanthrene.
The last possibility is now being tested. Methylcholanthrene-
treated F1 hybrid females developed mammary cancer precociously
if theywere bred and the female C3H parent provided the mammary
cancer milk-influence.
The foregoing discussion has dealt with the genetics of the host.
As in the case of other types of mouse neoplasia, the atypical cells
of leukemia are probably mutants.41 92 Susceptibility to transplanted
tissue depends on the genetic compatibility of tissue and host recipi-
ent. In general, neoplasms grow in the strain of origin and in F1
hybrids. A varying percentage of F2 hybrids do not grow inocu-
lated cells, but those resistant to one spontaneous neoplasm will, in
many cases, grow a second spontaneous tumor of the same strain.
This has been shown to be the case for leukemia. Iftransplantability
depends on the genetic constitution of transplanted cells and host,
and if the host remains constant, then the conclusion is that the gen-
etic constitution of the individual leukemias varies. Whether the
genic difference is the cause or the result of neoplasia has not been
proved. Furth and Barnes2' have found that the induced leukemias
of hybrid animals have a different transplantation pattern from that
of spontaneous leukemias in the same animals; the carcinogen has
not merely accelerated a spontaneous process but has induced a new
neoplasm with the accompanying cellular mutation.
Non-genetic influences and spontaneous leukemia
Maternoal influence: It has been established than an "influence"
contained in the breast-milk of high-mammary-cancer strains is
174EXPERIMENTAL MAMMALIAN LEUKEMIA
important in determining the development of mammary cancer in
these stocks.6 MacDowell and Richter reported 61, 65 what seemed
to be a similar although less marked "maternal influence" with ref-
erence to leukemia, the high-leukemia C58 strain and the low-leu-
kemia StoLi strain being reciprocally crossed in their studies. Origi-
nal foster-nursing experiments failed to demonstrate any milk-
influence. However, later experiments revealed that the incidence
of leukemia was higher in genetically identical mice foster-nursed
by Bagg-albino rather than by StoLi mice.68 In both of these
strains leukemia occurs only rarely. Although albino females had
a more potent influence on the incidence of leukemia than had
StoLi nurses, nurses from the high-leukemia strain had a still greater
influence than the albinos.
Barnes and Cole2 observed a decreased incidence of leukemia in
mice of a high-leukemia stock (Ak) fostered by females of low-leu-
kemia stocks (Af and Rf). Fostered animals died relatively early,
however, from intercurrent disease. Furth, Cole, and Boon'
obtained results similar to those of MacDowell and Richter with
respect to the incidence of leukemia in F1 hybrids, that is, the inci-
dence of leukemia was greater in F1 hy,brids whose mothers were of
the high-leukemia (Ak) rather than of the low-leukemia (C3H-
high-mammary-cancer) stock. The effect was more pronounced in
males. It was also found that foster-nursing by low-leukemia ('but
high-mammary-cancer) females significantly lowered the incidence
of leukemia in the high-leukemia stock. However, the offspring
of the fostered mice developed leukemia to as great a degree as the
original leukemic stock. The incidence of mammary cancer, on the
other hand, is low in the offspring of fostered mice of a high-mam-
mary-cancer strain.6 Since the high-mammary-cancer C3H females
were used in foster-nursing, the milk-influence of mammary cancer
and ofleukemia would seem to be different.
There was nothing to indicate that a specific "milk-influence" (as
for mammarycancer) was concerned in the development of leukemia
in the F strain of mice.49 The total and age incidences of leukemia
were not significantly different in the two groups of F1 hybrids
obtained byreciprocallycrossing strain F with low-leukemia animals.
When F1 hybrids were backcrossed to high- (strain F) and low-
(strains A and CBA) leukemia strains in such a manner that strain
F influence was supplied entirely by the male, the incidence of leu-
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kemia was at least as high as when only strain F females were used
in breeding to obtain F2 hybrids.
In addition, strain F mice were foster-nursed by animals of sev-
eral low-leukemia strains (CBA, I, A, C3H, NH). Transfer of the
young to foster mothers was effected within 24 hours after birth.
The incidence of leukemia was somewhat lower than the expected 55
per cent in strain F animals, but the animals did not survive as long
as unfostered strain F mice. Since the incidence of leukemia was
as high in the offspring of these animals as in strain F controls, it is
doubtful that this decreased incidence is to be considered significant.
A milk-influence has thus far been shown tobe extremely potent
only in the genesis of heritable mammary cancer in mice. Leukemia
does not differ, therefore, from certain other neoplasms for which
no milk-influence has been demonstrated. In no case has the mater-
nal influence, as revealed by F1 hybrids, been shown to be as sig-
nificant as it is in mammary cancer, where it may determine whether
the incidence of tumors is 90 per cent or 5 per cent. The most sig-
nificant difference was that demonstrated by MacDowell and Rich-
ter. In their experiments the life expectancy was considerably
higher in F1 hybrids whose mother was of the low-leukemia strain.
In these animals the incidence of leukemia was also lower and the
age of onset was later. The decreased total incidence might con-
ceivaEbly be explained on the basis of life expectancy, with, in this
group, a greater chance for death from causes other than leukemia.
Diet: The incidence of methylcholanthrene-induced leukemia in
sub-line 212 of strain dba was reduced from 90 to 10 per cent when
the animals were fed a diet low in cystine.10' This amino acid is
necessary for general body growth. However, body growth was
restricted by feeding mice a diet low in lysine and the incidence of
induced leukemia was still high.102 It is possible that cystine has a
specific effect on neoplastic as differentiated from general growth.
In the same strain and sub-lineof mice caloric restriction delayed the
onset and decreased the incidence of induced leukemia.41 Furth
has found that the incidence of spontaneous leukemia and the growth
of transplanted leukemia can be inhibited 'by underfeeding.20 If
transplanted into normal animals the lymph nodes of the underfed
mice exhibited progressive leukemic growth, indicating that under-
feeding does not inhibit neoplastic alteration per se. The incidence
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of leukemia was not significantly different in strain F mice fed diets
high and low in fat; the latent period of carcinogenic induction was
prolonged in strain dcba mice fed the high-fat diet, although the total
incidence of leukemia was not decreased.55
Endogenous hormones: The incidence of leukemia is higher in
the females of certain high-leukemia strains.'2 Administration of
estrogens also resulted in the appearance of leukemia in certain low-
leukemia strains.3" 32 Following ovariectomy the incidence of leu-
kemia was reduced in the high-leukemia Ak stock.70 However, leu-
kemia develops in both males and females of high-leukemia stocks,
and there is nothing to suggest a significantly increased leukemia
incidence in breeding as contrasted with virgin females; the inci-
dence of carcinogen-induced leukemia was higher in virgin than in
breeding females of the dba strain." Ovariectomy did not diminish
the incidence of leukemia nor delay the onset of the disease in
females of the F strain.40 In neither the induced disease in strain
dba7" nor the spontaneous disease in strain F was there evidence
that the sex hormones influence the appearance of the disease.
Although a significant rOle of the adrenal in the growth of trans-
planted rat leukemia has been suggested,94 there is as yet no evidence
that the onset of either spontaneous or carcinogen-induced leukemia
is affected by adrenalectomy or by the administration of adrenal-
cortical extract. These problems should be investigated in view of
the effect of adrenal cortex secretion on normal lymphopoiesis.4,35,88
The recently reported effect of thymectomy on the incidence of
spontaneous leukemia70 is startling; in the Ak stock the incidence of
the spontaneous disease was reduced from 60 to 8 per cent by this
procedure. Either a primary neoplastic focus is being removed, or
there is an endocrine effect. It is of interest that the thymus hyper-
trophies after adrenalectomy in the rat, and such animals were more
susceptible to transplanted leukemia.94 It seems unlikely that the
thymus would be the primary focus in such a large percentage of
leukemias. In the C58 strain it proved not to be one of the primary
foci.83 Although many mediastinal lymphosarcomas appear in the
F strain, the primary growth seems to be in the perithymic media-
stinal nodes rather than in the thymus itself. These results incidental
to thymectomy are so intriguing because the theory of an endocrine
function for the thymus has been rather generally discarded.
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Transplantation studies
It has not been possible to transfer'mammalian leukemia with
tissue extracts or blood plasma passed through bacterial filters,2' 41, 86
and leukemia has not resulted from inoculation of fragments of rup-
tured cells.28 Engelbreth-Holm and Frederiksen'6 suggested that
maintenance of anaerobic conditions during extraction of mammalian
leukemic tissues preserved a potent filterable agent. In one series
of experiments the onset of spontaneous leukemia in the C58 strain
was hastened by injection of the cobalt-cysteine mixture used by
Engelbreth-Holm in o(btaining anaercobic conditi'ons, but the exist-
ence of a virus involved in the passage of the disease could not be
esta!blished.67 In general, mouse neoplasms grow in the strain of
origin and in F, hybrids between this and a foreign strain.92 A
variable num'ber of F2 hybrids are susceptible to transplantation.
Mammary cancer or normal tissue of F, hybrids grew only in F,
hybrids and in neither parent stock.7 This transplantation pattern
was true for spontaneous leukemias of F, hybrids resulting from
mating of the high-leukemia F strain and low-leukemia strains.47
Strain F leukemias growing in F, hybrids are readily transplanted
into the strain F parent stock, indicating that the leukemic cells do
not arise from F, hybrid tissue.4' Leukemias arising in hybrids
between the Ak stock and low-leukemia stocks grew in the high-
leukemia parent stock, but not in the low-leukemia parents.87 Thus,
in this case susceptibility to transplantation and to the spontaneous
disease could be correlated.
Factors other than the genetic constitution of the recipient are
concerned in the transplantation of at least certain lines of leukemia.
When, after numerous passages, one line of leukemia of the C58
strain had become extremely malignant, it grew progressively in
the StoLi strain which had previously been resistant. Leukemic
cells will occasionally grow temporarily in untreated mice of a for- 58 eign strain. Irradiation of previously resistant mice induced sus-
ceptibility to inoculated cells.29' 5' Rats irradiated with x-rays have
grown leukemic cells of the mouse."6 Foster-nursing of resistant
mice has in certain instances made for susceptibility to transplanta-
tion.53 In the case of a line of rat leukemia, susceptibility has been
increased by adrenalectomy previous to inoculation,94 and decreased
by pre-transplantation injections of adrenal-cortical extract or
adrenotrophic hormone.76 The adrenals are perhaps concerned with
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the regulation of normal lymphopoiesis;4, 35 88 hyperplastic nodes
would seem to provide a more favorable environment for trans-
planted cells. However, x-irradiation reduces resistance to trans-
plantation and also causes the lymph nodes to become aplastic; con-
sequently, the lymphocyte has also been implicated in active resist-
ance to transplantation.74
Although transplantation has been accomplished successfully
with a single cell,28 there are sub-lethal doses of cells for certain
lines of transplanted leukemia.66 Inoculation of such doses resulted
in the induction of resistance to largerdoses of cells. This immunity
was passively transferred to previously untreated and susceptible
animals by inoculations of hepatic or splenic tissue of immune
animals.8' During the process of active immunization animals
developed systemic lesions which regressed.79 The same type of
immunity was produced by inoculations of either normal adult tissue
or embryonic tissue of foreign strains.66 This type of immunization
was possible with only certain genetic combinations of mice; in some
instances inoculation of normal tissue made for a more rapid growth
of transplanted leukemic cells. Immunity could be achieved against
neither spontaneous leukemia nor the cells arising in a spontaneous
case.63 Apparently the leukemic cells are altered by transplantation
so that their inoculation provokes an immune reaction. Immune
bodies were not present in high titer in the blood stream, but
apparently only in the tissues of high reticulo-endothelial content.82
In parajbiosis experiments the resistance to transplantation of one
mouse did not alterthe susceptibility of its twin.30 Immunity against
transplantaible leukemia has been provoked by inoculation of heat-
killed leukemic lymphocytes67 and also by injection of the sediment
derived from ultra-centrifugation of leukemic tissue extracts.68 In
these experiments the immunity might conceivably have been
induced by injection of a small number of viable leukemic cells
rather than by a non-cellular antigen. Immunity against a trans-
plantable rat leukemia has been provoked by inoculation of defi-
brinated blood or normal cells;93 this immune response has been
altered by administration of drugs.75
The more virulent the leukemia becomes, and the earlier death
supervenes following transplantation, the less extensive are the
lesions. Victor and Potter98 observed a marked drop in serum glu-
cose in association with one line of transplantable leukemia of high
malignancy. They were unable to relate this phenomenon to any
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particular mechanism causing death. The physiological character-
istics of leukemic lymphocytes may be altered by transplantation.
Lines of lymphocytes which produced leukemia with a blood picture
have (been known to produce an aleukemic type of disease, or the
reverse situation might hold.46 When the animal is moribund there
is greater likelihood of an outpouring of leukemic cells into the
blood. The "leukemic" and "sarcomatous" nature of lymphocytes
has been discussed.
Metabolism of mouse leukemia
The metabolism of spontaneous, transmitted,'3' 97 and induced
leukemia'0 resembles that of malignant tissue; the respiratory quo-
tient is less than unity and the rates of both aerobic and anerobic
glycolysis are greater than in normal lymph nodes. However, nor-
mal and leukemic nodes do not differ metabolically as widely as do
normal and malignant tissues of other types; normal mouse lymph
nodes possess a definite but not large anaerobic and aerobic glycolysis.
The qualitative metabolic change exists, although the quantitative
change is of low magnitude. The reports in the literature concern-
ing the metabolism of human leukemic cells are conflicting39 (see
Forkner). Arnow, Opsahl, and Watson were unable to extract
racemic glutamic acid from a human leukemic spleen, although they
considered d-glutamic acid to be characteristic of true neoplastic
tissue.'
Experimental therapy
The effects of radium and x-irradiation on the growth of mouse
leukemia have been tested experimentally. Only slight prolonga-
tion of life was observed when animals were inoculated with leu-
kemic cells and then irradiated with x-rays29 or exposed to radium;27
systemic leukemia could not be cured. Administration of radioac-
tive phosphorus had no influence on the course of transplanted lym-
phatic or myelogenous leukemia.56 Leukemic tissue had no greater
content of phosphorus than normal lymphoid tissue, but the phos-
phorus exchange was greater than normal. The therapeutic effects
of various sulfonamides and arsenicals, and of lbenzol, irradiation,
and underfeeding were tested on the course of transplanted leu-
kemia.18 Although benzol, irradiation, and underfeeding retarded
the progressive growth of leukemic cells of certain lines, the life of
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inoculated animals was in general neither consistently nor strikingly
prolonged. Colchicine, a so-called "radiomimetic" drug, and sura-
min, a non-arsenical trypanosomide, inhibited the growth of local
lymphoid tumors temporarily.6" 103 Both colchicine and suramin
were toxic in "therapeutic" doses. Administration of adrenal-corti-
cal extracts or adrenotrophic hormone might conceivably inhibit the
growth of lymphoid tumors, judging from the effect of cortical
extract on normal lymphopoiesis.
Studies on therapy have been carried out on transplanted leu-
kemia. Since the spontaneous disease is more comparable to human
leukemia, it would seem desirable that investigations be made on
cases of the spontaneous disease within a high-leukemia strain.
Untreaited cases should serve as adequate controls. One of the diffi-
culties in such experimentation, as in the case of clinical medicine,
is that most cases are seen in the terminal. state. If there were a
sure means of early diagnosis (in the C58 strain diagnosis has been
made at the inception of the disease), then x-ray therapy would
receive a more adequate test.
The average period of induction of leukemia with methylchol-
anthrene in strain dba (sub-line 212) is 90 to 100 days. After the
administration of carcinogen for 60 to 70 days 'the animals received
960 r by fractional irradiation.37 The date of onset of leukemia was
not delayed by such treatment. Treatment of animals with spon-
taneous mediastinal lymphosarcoma with one dose of 360 r resulted
in clinical improvement and prolongation of life, probalbly because
of release of mediastinal pressure. Similar treatment of animals
with systemic leukemia induced regression in the size of the spleen
and lymph nodes; there was, however, subsequent enlargement.
Survival was not longer than in control animals.
Summary
1. Spontaneous leukemia occurs in a large proportion of mice
of several inbred strains; the disease can be induced in others by
various means. Thus, experimental material is available for study
of the causation, diagnosis, and treatment of leukemia.
2. Mouse leukemia is probably the same disease as that seen in
man. Experimental evidence is in favor of the neoplastic nature
of the disease, all investigators of rodent leukemia being in agree-
ment. Lymphosarcoma and leukemia would seem to be different
morphological manifestations of the same fundamental disease proc-
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ess; the classification of adisease as "lymphosarcoma" or "leukemia"
is in many cases arbitrary. Experimental work does not support the
concept of "systemic" or multicentric origin of spontaneous leukemia,
although carcinogen-induced leukemia may, as in the case of induced
lung and breast tumors, have multicentric foci of origin appearing
simultaneously.
3. It has not been possilble to transmit mammalian leukemia by
inoculation of tissue extracts or blood plasma passed through bac-
terial filters, and leukemia has not resulted from inoculation of frag-
ments of ruptured cells. Mammalian leukemia is transferable by
inoculation of only viable leukemic cells into a susceptible host,
usually of close genetic relationship. Factors other than genetic
constitution (x-ray, partial immunization, adrenal hormones, increase
in cellular malignancy) may modify transplantation in so far as
growth per se or character of the leukemic growth is concerned.
Immunity to transplanted leukemia has resulted from inoculation
of sublethal doses of cells, injections of suspensions of normal tissue
cells of certain genetic constitution, administration of heat-killed
leukemic cells, ultracentrifuged leukemic cell extracts, or normal
defibrinated blood. Immunity has been passively transferred by
inoculation of liver and spleen of immune animals. It has not been
possilble to immunize against either the spontaneous disease or the
cells of a spontaneous case of leukemia.
4. Multiple agents can induce leukemia in mice; these are
carcinogens, x-rays, estrogens, and the unknown stimulants respon-
sible for the spontaneous disease. Mice of only certain genetic con-
stitution are susceptible to only certain agents. Genetic suscepti-
bility to one agent, or to the spontaneous disease, is not necessarily
correlated with susceptibility to other leukemogenic agents. Syner-
gists can condition the response to carcinogens, but their effectiveness
varies with the strain of animals involved.
5. Uniform results have not been obtained in studies on the
genetics of mouse leukemia, the incidence of leukemia in hybrid
crosses varying with the high- and low-leukemia strains used.
Whether this discrepancy is apparent or real depends on whether
or not the data of different investigators are comparable. The onset
of leukemia is delayed in hybrid animals as compared with mice of
the high-leukemia stocks. This delay could in one study be cor-
related with (1) the degree of inheritance from the high-leukemia
stock and/or (2) the increased life expectancy in hybrids. The
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total percentage of leukemia was as high in certain hybrid crosses
as in the pure stock. Leukemic cells differ genetically for each
spontaneous case, as proven by transplantation experiments, the
assumption being that somatic mutation is associated with neoplastic
development. Transplantation patterns of carcinogen-induced leu-
kemia suggest induction of somatic mutations which do not occur
spontaneously.
6. The breast-milk of certain strains of mice has been reported
to contain a material which influences the total incidence of leukemia
in genetically susceptible animals. The material would seem not
to be identical with the mammary cancer "milk-influence" nor as
necessary for the development of "genetic" leukemia as is the latter
for mouse mammary cancer of the "genetic" type. The influence
which for the present is designatedas "genetic" is the only one which
thus far has been demonstrated as essential for tihe appearance of
leukemia in successive generations of inbred mice.
7. Feeding of a diet low in cystine has resulted in a reduced
incidence of carcinogen-induced leukemia. A diet low in lysine did
not influence the induction of leukemia similarly, although general
body growth was inhibited by deficiency of either amino acid. The
incidence ofdeath from spontaneous leukemia was lowered in a high-
leukemia strain of mice by underfeeding; neoplastic alteration per
se was not inhibited, as demonstrated by progressive growth upon
transplantation of lymph nodes of experimental animals into normal
mice. Varying the amount of fat in the diet did not affect the onset
of spontaneous leukemia; on a high-fat diet the induction time of
methylcholanthrene-induced leukemia was prolonged.
8. Although the incidence of leukemia is higher in females of
certain strains, and large doses oT estrogens have been shown to be
leukemogenic for certain mice, the importance of endogenous estro-
gen in the development of mouse leukemia would seem to be
relatively minor, ascompared, for instance, with the role of estrogens
in mammary cancer development. Adrenal-cortical hormones
might be involved in the development of leukemic lesions, absence
of adrenal secretion having been reported to favor the growth of
rat leukemic cells. It has not yet 'been determined whether inhibi-
tion of lymphopoiesis tby cortical extracts will affect the onset of
either induced or spontaneous leukemia. Recent experiments sug-
gest that the thymus gland might in some undetermined manner
influence the development of spontaneous leukemia in mice.
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9. The metabolism of mouse leukemic tissue qualitatively
resembles that of malignant tissues, but the deviation from normal
is of lesser magnitude.
10. Experiments on genesis and therapy of mouse leukemia
have thus far yielded no suggestion for improving methods of early
diagnosis or treatment of the human disease.
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ADDENDUM
After this manuscript had been submitted for publication two articles
that should be included in this review appeared in print. The first, by Heil-
man and Kendall (Endocrinology, 1944, 34, 416), presents observations on
regression of a transplanted lymphosarcoma of the mouse upon administration
of a crystalline hormone of the adrenal cortex. The second, by Saxton, Boon,
and Furth (Cancer Research, 1944, 4, 401), provides evidence that the spon-
taneous leukemic transformation of cells can be delayed, but not entirely pre-
vented, by underfeeding in mice of the high-leukemia Ak stock. The inci-
dence of leukemia was reduced from 65 to 10 per cent.